Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal Forebrain

Whitehouse, PJ, Price, DL, Struble, RG, Clark, AW, Coyle, JT, DeLong, Mahlon R.·1982·Science
DOI 10.1126/science.7058341

Cited by (1,021)

Items 101–200 of 1,021

  1. Integrated multimodal cell atlas of Alzheimer’s disease
    Gabitto, Mariano I., Travaglini, Kyle J., Rachleff, Victoria M., Kaplan, Eitan S., Long, Brian, Ariza, Jeanelle, Ding, Yi, Mahoney, Joseph T., Dee, Nick, Goldy, Jeff et al. · 2024 · Nature Neuroscience
  2. Immunocytochemical localization of choline acetyltransferase in rat cerebral cortex: A study of cholinergic neurons and synapses
    Carolyn R. Houser, G. D. Crawford, Paul M. Salvaterra, James E. Vaughn · 1985 · The Journal of Comparative Neurology
  3. Astrocyte Heterogeneity: Impact to Brain Aging and Disease
    Matias, Isadora, Morgado, Juliana, Gomes, Flávia Carvalho Alcantara · 2019 · Frontiers in Aging Neuroscience
  4. Expression of the Alzheimer amyloid precursor gene transcripts in the human brain
    Rachael L. Neve · 1988 · Neuron
  5. Cortical projection patterns of the medial septum‐diagonal band complex
    Ronald Petrus Albertus Gaykema, Paul G.M. Luiten, Csaba J. Nyakas, J. Traber · 1990 · The Journal of Comparative Neurology
  6. Cholinesterase Inhibitors: A New Class of Psychotropic Compounds
    Jeffrey L. Cummings · 2000 · American Journal of Psychiatry
  7. The Cholinergic Hypothesis: A Historical Overview, Current Perspective, and Future Directions
    Raymond T. Bartus, Reginald L. Dean, Michael J. Pontecorvo, Charles Flicker · 1985 · Annals of the New York Academy of Sciences
  8. Seizures produced by pilocarpine in mice: A behavioral, electroencephalographic and morphological analysis
    Waldemar Andrzej Turski, Ésper A. Cavalheiro, Zuner Assis Bortolotto, Luiz M. Mello, Michael Schwarz, Lechosław Turski · 1984 · Brain Research
  9. Localization of high-affinity binding sites for oxytocin and vasopressin in the human brain. An autoradiographic study
    Loup, F., Tribollet, E., Dubois-Dauphin, M., Dreifuss, J.J. · 1991 · Brain Research
  10. Nerve growth factor increases choline acetyltransferase activity in developing basal forebrain neurons
    William Cary Mobley, Julia Lynn Rutkowski, Gihan I Tennekoon, Jude Gemski, Karen Buchanan, Michael V. Johnston · 1986 · Molecular Brain Research
  11. Observations in a preliminary open trial of estradiol therapy for senile dementia-alzheimer's type
    Howard M Fillit, Herman J. Weinreb, Ina N. Cholst, Victoria N. Luine, Bruce S. McEwen, Roberto Amador, John B. Zabriskie · 1986 · Psychoneuroendocrinology
  12. The history of the cholinergic hypothesis
    Antonio Contestabile · 2010 · Behavioural Brain Research
  13. Therapeutic AAV Gene Transfer to the Nervous System: A Clinical Reality
    Eloïse Hudry, Luk H. Vandenberghe · 2019 · Neuron
  14. Behavioral and neurochemical effects following neurotoxic lesions of a major cholinergic input to the cerebral cortex in the rat1
    Charles Flicker, R DEAN, Dorothy L. Watkins, S FISHER, Raymond T. Bartus · 1983 · Pharmacology Biochemistry and Behavior
  15. Nucleus basalis of Meynert revisited: anatomy, history and differential involvement in Alzheimer’s and Parkinson’s disease
    Alan King Lun Liu, Raymond Chuen‐Chung Chang, R. K. B. Pearce, Steve Gentleman · 2015 · Acta Neuropathologica
  16. Revisiting the Cholinergic Hypothesis in Alzheimer's Disease: Emerging Evidence from Translational and Clinical Research
    Harald Juergen Hampel, Marsel M. Mesulam, A. Claudio Cuello, Ara S. Khachaturian, Andrea Vergallo, Martin Rhys Farlow, Peter Jeffrey Snyder, Ezio Giacobini, Zaven S. Khachaturian · 2019 · The Journal of Prevention of Alzheimer s Disease
  17. Intrahippocampal Septal Grafts Ameliorate Learning Impairments in Aged Rats
    Fred H. Gage, Anders Björklund, Ulf Stenevi · 1984 · Science
  18. GDNF prevents degeneration and promotes the phenotype of brain noradrenergic neurons in vivo
    Ernest Arenas, Miles Trupp, Peter Åkerud, Carlos F. Ibáñez · 1995 · Neuron
  19. Acetylcholine, Aging, and Alzheimer's Disease
    Janice L. Muir · 1997 · Pharmacology Biochemistry and Behavior
  20. The car☐yl third of tau is tightly bound to paired helical filaments
    Jun Kondo, Toshiyuki Honda, Hiroshi Mori, Yoshio Hamada, Reiko Miura, Midori OGAWARA, Yasuo Ihara · 1988 · Neuron
  21. EEG coherence in Alzheimer's disease
    T. Locatelli, Marco Cursi, Diego Liberati, M. Franceschi, Giancarlo Comi · 1998 · Electroencephalography and Clinical Neurophysiology
  22. Spatial navigation in normal aging and the prodromal stage of Alzheimer's disease: Insights from imaging and behavioral studies
    Ségolène Lithfous, André Dufour, Olivier Després · 2012 · Ageing Research Reviews
  23. Sleep and quantitative EEG in neurodegenerative disorders
    Dominique Petit, Jean‐François Gagnon, Maria Livia Fantini, Luigi Ferini‐Strambi, Jacques Yves Montplaisir · 2004 · Journal of Psychosomatic Research
  24. Behavioural, biochemical and histochemical effects of different neurotoxic amino acids injected into nucleus basalis magnocellularis of rats
    S.B. Dunnett, Ian Q. Whishaw, Graham H. Jones, Steven Bunch · 1987 · Neuroscience
  25. ALZHEIMER'S PRESENILE DEMENTIA, SENILE DEMENTIA OF ALZHEIMER TYPE AND DOWN'S SYNDROME IN MIDDLE AGE FORM AN AGE RELATED CONTINUUM OF PATHOLOGICAL CHANGES
    David M. A. Mann, Peter O. Yates, Borys Marcyniuk · 1984 · Neuropathology and Applied Neurobiology
  26. Nerve growth factor mRNA in peripheral and central rat tissues and in the human central nervous system: Lesion effects in the rat brain and levels in Alzheimer's disease
    Michel Goedert, A. Fine, Stephen P. Hunt, Axel Ullrich · 1986 · Molecular Brain Research
  27. Animal models of Alzheimer's disease: experimental cholinergic denervation
    Gwenn S. Smith · 1988 · Brain Research Reviews
  28. Drug development for CNS disorders: strategies for balancing risk and reducing attrition
    Menelas N. Pangalos, Lee E. Schechter, Orest Hurko · 2007 · Nature Reviews Drug Discovery
  29. Failed retrograde transport of NGF in a mouse model of Down's syndrome: Reversal of cholinergic neurodegenerative phenotypes following NGF infusion
    Cooper, Jonathan D., Salehi, Ahmad, Delcroix, Jean-Dominique, Howe, Charles L., Belichenko, Pavel V., Chua-Couzens, Jane, Kilbridge, Joshua F., Carlson, Elaine J., Epstein, Charles J., Mobley, William C. · 2001 · Proceedings of the National Academy of Sciences
  30. Differential Patterns of Memory Loss Among Patients With Alzheimer's Disease, Huntington's Disease, and Alcoholic Korsakoff's Syndrome
    Mark B. Moss, Marilyn Albert, Nelson Butters, Mark Payne · 1986 · Archives of Neurology
  31. Persistence of cholinergic neurons in the basal nucleus in a brain with senile dementia of the Alzheimer's type demonstrated by immunohistochemical staining for choline acetyltransferase
    R.C.A. Pearson, Michael V. Sofroniew, A. Claudio Cuello, T.P.S. Powell, Felix P. Eckenstein, Margaret M. Esiri, Gordon Keith Wilcock · 1983 · Brain Research
  32. ALZHEIMER'S DISEASE: Genetic Studies and Transgenic Models
    Price, Donald L., Tanzi, Rudolph E., Borchelt, David R., Sisodia, Sangram S. · 1998 · Annual Review of Genetics
  33. Coexistence of peptides with classical neurotransmitters
    Tomas G. M. Hökfelt, David E. Millhorn, Kim B. Seroogy, Yoshihiro Tsuruo, Sandra Ceccatelli, Bj�rn Lindh, Björn Meister, Tor Melander, Martin Schalling, Tamás Bartfai et al. · 1987 · Cellular and Molecular Life Sciences
  34. β-Amyloid peptide blocks the response of α7-containing nicotinic receptors on hippocampal neurons
    Qing-song Liu, H. Kawai, D. Berg · 2001 · Proceedings of the National Academy of Sciences of the United States of America
  35. Anatomy and physiology of central galanin-containing pathways
    Istvan Merchenthaler, FRANCISCO JOSÉ LÓPEZ, Andres F. Negro-Vilar · 1993 · Progress in Neurobiology
  36. Cholinergic dysfunction in diseases with Lewy bodies
    R. C. Dodel, Yan-Sheng Du, K. Bales, Feng Gao, B. Eastwood, B. Glazier, R. Zimmer, Barbara Cordell, A. Hake, R. Evans et al. · 2000 · Neurology
  37. Transmitter deficits in Alzheimer's disease
    John Hardy, Rolf Adolfsson, Irina I. Alafuzoff, Gösta Bucht, Jan O. Marcusson, Per Nyberg, Eva Perdahl, Per Olov Wester, Bengt G. Winblad · 1985 · Neurochemistry International
  38. Quantitation of BDNF mRNA in human parietal cortex by competitive reverse transcription-polymerase chain reaction: decreased levels in Alzheimer's disease
    R. M. Damian Holsinger, Jane Schnarr, Pauline Henry, Vivian T Castelo, Margaret L. Fahnestock · 2000 · Molecular Brain Research
  39. Blood-Brain Barrier Penetration and in Vivo Activity of an NGF Conjugate
    Phillip M. Friden, Lee R. Walus, Patricia M. Watson, Susan R. Doctrow, John W. Kozarich, Cristina M. Bäckman, Hanna Bergman, Barry J. Hoffer, Floyd E. Bloom, Ann‐Charlotte Granholm · 1993 · Science
  40. Clinical pharmacology of rivastigmine: a new-generation acetylcholinesterase inhibitor for the treatment of alzheimer's disease
    Ronald J. Polinsky · 1998 · Clinical Therapeutics
  41. Cognitive Mechanisms of Nicotine on Visual Attention
    Natalia Lawrence, Thomas J. Ross, Elliot A. Stein · 2002 · Neuron
  42. Thyroid hormones, brain function and cognition: a brief review
    Joshua A. Smith · 2002 · Neuroscience & Biobehavioral Reviews
  43. A review of butyrylcholinesterase as a therapeutic target in the treatment of Alzheimer’s disease
    Nordberg, Agneta, Ballard, Clive, Bullock, Roger, Darreh-Shori, Taher, Somogyi, Monique · 2013 · The Primary Care Companion For CNS Disorders
  44. Conditioned and Unconditioned Stimuli Increase Frontal Cortical and Hippocampal Acetylcholine Release: Effects of Novelty, Habituation, and Fear
    Elio Acquas, Catriona Wilson, Hans C. Fibiger · 1996 · Journal of Neuroscience
  45. Galanin-like immunoreactivity in cholinergic neurons of the septum-basal forebrain complex projecting to the hippocampus of the rat
    Tor Melander, William A. Staines, Tomas G. M. Hökfelt, Åke Rökaeus, Felix P. Eckenstein, Paul M. Salvaterra, Bruce H. Wainer · 1985 · Brain Research
  46. Say NO to Alzheimer's disease: the putative links between nitric oxide and dementia of the Alzheimer's type
    A Law · 2001 · Brain Research Reviews
  47. Role of High-Affinity Receptors and Membrane Transporters in Nonsynaptic Communication and Drug Action in the Central Nervous System
    E. Sylvester Vizi · 2000 · Pharmacological Reviews
  48. Essential role of neocortical acetylcholine in spatial memory
    Jürgen Winkler, Steven T. Suhr, Fred H. Gage, Leon J. Thal, L. J. Fisher · 1995 · Nature
  49. Correlates of p53- and Fas (CD95)-mediated apoptosis in Alzheimer's disease
    de la Monte, Suzanne M, Sohn, Yoon K, Wands, Jack R · 1997 · Journal of the Neurological Sciences
  50. Pathophysiologic relationship between Alzheimer's disease, cerebrovascular disease, and cardiovascular risk: A review and synthesis
    Santos, Cláudia Y., Snyder, Peter J., Wu, Wen‐Chih, Zhang, Mia, Echeverria, Ana, Alber, Jessica · 2017 · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
  51. Biochemical changes in Dementia disorders of Alzheimer type (AD/SDAT)
    Carl‐Gerhard Gottfries, Rolf Adolfsson, Sten‐Magnus Aquilonius, Avid Carlsson, S.‐Å. Eckernäs, Agneta K. Nordberg, Lars Oreland, Lars T. Svennerholm, Åsa Wiberg, Bengt G. Winblad · 1983 · Neurobiology of Aging
  52. Inhibitory effect of curcuminoids on acetylcholinesterase activity and attenuation of scopolamine-induced amnesia may explain medicinal use of turmeric in Alzheimer’s disease
    Ahmed, Touqeer, Gilani, Anwarul-Hassan · 2009 · Pharmacology Biochemistry and Behavior
  53. Down syndrome and the complexity of genome dosage imbalance
    S. Antonarakis · 2016 · Nature reviews genetics
  54. Role of the nicotinic acetylcholine receptor in Alzheimer's disease pathology and treatment
    Sylvia Lombardo, Uwe Maskos · 2014 · Neuropharmacology
  55. Anticholinergic Sensitivity in Patients With Dementia of the Alzheimer Type and Age-Matched Controls
    Trey Sunderland · 1987 · Archives of General Psychiatry
  56. Distribution and retrograde transport of trophic factors in the central nervous system: functional implications for the treatment of neurodegenerative diseases
    Elliott Jay Mufson, Jeffrey S. Kroin, Timothy J. Sendera, Teresa Sobreviela · 1999 · Progress in Neurobiology
  57. Synaptic structural abnormalities in the Ts65Dn mouse model of down syndrome
    Belichenko, Pavel V., Masliah, Eliezer, Kleschevnikov, Alexander M., Villar, Angela J., Epstein, Charles J., Salehi, Ahmad, Mobley, William C. · 2004 · Journal of Comparative Neurology
  58. MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD
    Clifford R. Jack, M. Slomkowski, Stephen I. Gracon, Toni M. Hoover, Joel P. Felmlee, Keith Stewart, Yun Xu, Maria S. Shiung, Peter C. O’Brien, R. Cha et al. · 2003 · Neurology
  59. The role of G protein-coupled receptors in the pathology of Alzheimer's disease
    Thathiah, Amantha, De Strooper, Bart · 2011 · Nature Reviews Neuroscience
  60. Human cholinergic basal forebrain: chemoanatomy and neurologic dysfunction
    Elliott Jay Mufson, Stephen D. Ginsberg, Miloš D. Ikonomović, Steven Trent DeKosky · 2003 · Journal of Chemical Neuroanatomy
  61. Cortical projection patterns of magnocellular basal nucleus subdivisions as revealed by anterogradely transportedPhaseolus vulgaris leucoagglutinin
    Paul G.M. Luiten, Ronald Petrus Albertus Gaykema, J. Traber, David G. Spencer · 1987 · Brain Research
  62. Axonal Transport and Alzheimer's Disease
    Gorazd Bernard Stokin, Lawrence S.B. Goldstein · 2006 · Annual Review of Biochemistry
  63. Progressive decline in spatial learning and integrity of forebrain cholinergic neurons in rats during aging
    Walter Fischer, Karen S. Chen, Fred H. Gage, Anders Björklund · 1992 · Neurobiology of Aging
  64. gamma-Aminobutyric acid-containing basal forebrain neurons innervate inhibitory interneurons in the neocortex.
    T. Freund, V. Meskenaite · 1992 · Proceedings of the National Academy of Sciences of the United States of America
  65. Neuroprotective Actions of Dietary Choline
    Blusztajn, Jan, Slack, Barbara, Mellott, Tiffany · 2017 · Nutrients
  66. Noninvasive in vivo assessment of cholinergic cortical circuits in AD using transcranial magnetic stimulation
    V. Di Lazzaro, A. Oliviero, P. Tonali, C. Marra, A. Daniele, P. Profice, E. Saturno, F. Pilato, C. Masullo, J. Rothwell · 2002 · Neurology
  67. Executive function deficits in mild Alzheimer's disease.
    Ginette Lafleche, Marilyn Albert · 1995 · Neuropsychology
  68. Impaired learning of a motor skill in patients with Huntington's disease.
    William C. Heindel, Nelson Butters, David P. Salmon · 1988 · Behavioral Neuroscience
  69. Muscarinic cholinergic receptor subtypes in the human brain. II. Quantitative autoradiographic studies
    Roser Cortés, A. Probst, Hans-Jakob Tobler, J.M. Palacios · 1986 · Brain Research
  70. Characterization of l ‐[3H]Nicotine Binding in Human Cerebral Cortex: Comparison Between Alzheimer's Disease and the Normal
    Donna D. Flynn, Deborah C. Mash · 1986 · Journal of Neurochemistry
  71. Survival of Adult Basal Forebrain Cholinergic Neurons After Loss of Target Neurons
    Michael V. Sofroniew, Neil P. Galletly, Ole Isacson A, Clive Niels Svendsen · 1990 · Science
  72. DEMENTIA
    Martin N. Rossor · 1982 · The Lancet
  73. Attentional functions of the forebrain cholinergic systems: effects of intraventricular hemicholinium, physostigmine, basal forebrain lesions and intracortical grafts on a multiple-choice serial reaction time task
    J. L. Muir, Stephen B. Dunnett, Trevor William Robbins, Barry J. Everitt · 1992 · Experimental Brain Research
  74. Cell loss and shrinkage in the nucleus basalis Meynert complex in Alzheimer's disease
    Oscar J.M. Vogels, Cees A. J. Broere, Henk J Ter Laak, Hans J. ten Donkelaar, Rudolf Nieuwenhuys, B.P.M. Schulte · 1990 · Neurobiology of Aging
  75. Selectivity of Cholinesterase Inhibition
    Marta Weinstock · 1999 · CNS Drugs
  76. Loss of nerve growth factor receptor-containing neurons in Alzheimer's disease: A quantitative analysis across subregions of the basal forebrain
    Elliott Jay Mufson, Mark A. Bothwell, Jeffrey H. Kordower · 1989 · Experimental Neurology
  77. Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice
    Simona Capsoni, Gabriele Ugolini, A Comparini, Francesca Ruberti, Nicoletta Berardi, Antonino Cattaneo · 2000 · Proceedings of the National Academy of Sciences
  78. Dementia in idiopathic Parkinson's disease
    Patrícia Gaspar, Françoise Gray · 1984 · Acta Neuropathologica
  79. Alzheimer's disease: a correlative study.
    D. Neary, Julie S. Snowden, David M. A. Mann, David M. Bowen, Neil R. Sims, Bernice Northen, Peter O. Yates, ALAN N. DAVISON · 1986 · Journal of Neurology Neurosurgery & Psychiatry
  80. Medial ganglionic eminence–like cells derived from human embryonic stem cells correct learning and memory deficits
    Yan Liu, Jason Porter Weick, Huisheng Liu, Robert Krencik, Xiaoqing Zhang, Lixiang Ma, Guomin Zhou, Melvin Ayala, Su‐Chun Zhang · 2013 · Nature Biotechnology
  81. Regulation of mitochondrial pyruvate dehydrogenase activity by tau protein kinase I/glycogen synthase kinase 3beta in brain.
    Minako M. Hoshi, Akihiko Takashima, Kei Noguchi, M Murayama, Michio Sato, Shunzo Kondo, Yoshikatsu Saitoh, K. Ishiguro, T Hoshino, Kazutomo Imahori · 1996 · Proceedings of the National Academy of Sciences
  82. Activation of the genetically defined m1 muscarinic receptor potentiates N -methyl- d -aspartate (NMDA) receptor currents in hippocampal pyramidal cells
    Michael J. Marino, Susan T. Rouse, Allan I. Levey, Lincoln T. Potter, Peter Jeffrey Conn · 1998 · Proceedings of the National Academy of Sciences
  83. Cnidarians as a Source of New Marine Bioactive Compounds—An Overview of the Last Decade and Future Steps for Bioprospecting
    Joana Rocha, Luísa Maria Sobreira Vieira Peixe, Newton C. M. Gomes, Ricardo Calado · 2011 · Marine Drugs
  84. Galanin hyperinnervates surviving neurons of the human basal nucleus of meynert in dementias of alzheimer's and parkinson's disease: A hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia
    Victoria Chan‐Palay · 1988 · The Journal of Comparative Neurology
  85. Retinoic Acid Attenuates β-Amyloid Deposition and Rescues Memory Deficits in an Alzheimer's Disease Transgenic Mouse Model
    Ding, Yun, Qiao, Aimin, Wang, Ziqing, Goodwin, J. Shawn, Lee, Eun-Sook, Block, Michelle L., Allsbrook, Matthew, McDonald, Michael P., Fan, Guo-Huang · 2008 · The Journal of Neuroscience
  86. Metabotropic glutamate receptors and neurodegenerative diseases
    Fabiola Mara Ribeiro, Luciene Bruno Vieira, Rita Gomes Wanderley Pires, Roenick Proveti Olmo, Stephen S. G. Ferguson · 2016 · Pharmacological Research
  87. Depression in neurodegenerative diseases: Common mechanisms and current treatment options
    Ciarán Galts, Luis E.B. Bettio, David C. Jewett, Charles C. Yang, Patrícia S. Brocardo, Ana Lúcia S. Rodrigues, Jonathan S. Thacker, Joana Gil‐Mohapel · 2019 · Neuroscience & Biobehavioral Reviews
  88. Distribution of gabaergic and cholinergic neurons in the rat diagonal band
    H. Robert Brashear, László Záborszky, Lennart Heimer · 1986 · Neuroscience
  89. Nicotinic System Involvement in Alzheimer??s and Parkinson??s Diseases
    PAUL A. NEWHOUSE, Alexandra Potter, Edward D. Levin · 1997 · Drugs & Aging
  90. Brain angiotensin receptor subtypes in the control of physiological and behavioral responses
    John W. Wright, Joseph W. Harding · 1994 · Neuroscience & Biobehavioral Reviews
  91. The Cholinergic System Modulates Memory and Hippocampal Plasticity via Its Interactions with Non-Neuronal Cells
    Sara V. Maurer, Christina L. Williams · 2017 · Frontiers in Immunology
  92. Advances in the Treatment of Alzheimer’s Disease: Benefits of Dual Cholinesterase Inhibition
    Clive G. Ballard · 2002 · European Neurology
  93. Muscarinic acetylcholine receptors in the hippocampus, neocortex and amygdala: a review of immunocytochemical localization in relation to learning and memory
    Eddy A. van der Zee, Paul G.M. Luiten · 1999 · Progress in Neurobiology
  94. Parkinson's disease: Neuron loss in the nucleus basalis without concomitant Alzheimer's disease
    Imaharu Nakano, Asao Hirano · 1984 · Annals of Neurology
  95. Sleep-related neuronal discharge in the basal forebrain of cats
    Ronald S. Szymusiak, Dennis McGinty · 1986 · Brain Research
  96. Donepezil: an update
    Ben Seltzer · 2007 · Expert Opinion on Pharmacotherapy
  97. Amyloid Protein Precursor Messenger RNAs: Differential Expression in Alzheimer's Disease
    Mark R. Palmert, Todd Eliot Golde, Mark L. Cohen, D. M. Kovacs, Rudolph E. Tanzi, James F. Gusella, M. Usiak, Linda H. Younkin, Steven G. Younkin · 1988 · Science
  98. Down regulation of trk but not p75NTR gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer's disease
    Stephen D. Ginsberg, Shaoli Che, Joanne Wuu, Scott Counts, Elliott Jay Mufson · 2006 · Journal of Neurochemistry
  99. Reciprocal changes in corticotropin-releasing factor (CRF)-like immunoreactivity and CRF receptors in cerebral cortex of Alzheimer's disease
    Errol B. De Souza, Peter John Whitehouse, Michael J. Kuhar, Donald L. Price, Wylie Vale · 1986 · Nature
  100. Somatostatin immunoreactive neurons in the human hippocampus and cortex shown by immunogold/silver intensification on vibratome sections: Coexistence with neuropeptide Y neurons, and effects alzheimer‐type dementia
    Chan‐Palay, V. · 1987 · Journal of Comparative Neurology